| Read Time: < 1 minute | Dangerous Drugs

Merck & Co. Ordered to Disclose Internal Emails In Zostavax Lawsuit

December 23, 2020 — Judge Harvey Bartle ruled that all but part of one of the 22 documents in dispute were not shielded by the attorney-client privilege.  Accordingly, Merck & Co. is required to disclose internal emails about potential changes to the label of Zostavax, which could reveal its knowledge of the adverse effects its vaccine was causing long...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Generic Ranitidine Manufacturers Claim Plaintiffs Have Not Been Injured

The U.S. Food and Drug Administration (FDA) recalled all Zantac (ranitidine) antacid products from the market on April1, 2020, based on evidence that the products tested positive for unsafe levels of N-nitroso dimethylamine (NDMA), a cancer-causing substance. Since that time, many plaintiffs, who took the medication and were diagnosed with cancer, have filed against the makers of Zantac and...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Sanofi Faces Financial Conduct Authority Claims

November 12, 2020 — U.S. District Judge Anita B. Brody “trimmed” claims accusing Sanofi’s predecessor, Aventis Pharmaceuticals, of false advertising and giving kickbacks to physicians who promoted Taxotere.  Claims stated that between 1996 and 2004, the drug manufacturer paid doctors to attend advisory boards focused on advertising Taxotere.  The doctors then prescribed Taxotere or off-brand versions of Taxotere to...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Taxotere Trial Schedule Update November 6, 2020

November 6, 2020 — “The Court amended certain pretrial deadlines for the third, fourth, and fifth bellwether trials.” Reference: “United States District Court.” MDL – 2740 Taxotere (Docetaxel) Products Liability Litigation | Eastern District of Louisiana | United States District Court, 28 Dec. 2020, www.laed.uscourts.gov/case-information/mdl-mass-class-action/taxotere.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Timeline For Zantac Class Action Discovery

October 5, 2020 — On October 5, 2020, Judge Rosenberg ordered a timeline for class action discovery in Pretrial Order #49.  The timeline runs from October 23, 2020 to December 20, 2021, which is the deadline for fact discovery and class motions. Reference:  “United States District Court.” 20-MD-2924-Rosenberg – In Re: Zantac (Ranitidine) Products Liability Litigation | Southern District...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Taxotere Trial Schedule Update August 19, 2020

August 19, 2020 — “Per the parties’ agreement, the Court amended certain pretrial deadlines and trial dates.” Reference: “United States District Court.” MDL – 2740 Taxotere (Docetaxel) Products Liability Litigation | Eastern District of Louisiana | United States District Court, 28 Dec. 2020, www.laed.uscourts.gov/case-information/mdl-mass-class-action/taxotere

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Department of Justice Investigates Zantac Manufacturers

August 1, 2020 – The Department of Justice (DOJ) investigated Sanofi-Aventis US LLC and GlaxoSmithKline LLC regarding the allegations that the heartburn drug, Zantac, caused cancer. The DOJ and U.S. Attorney’s Office were specifically interested in whether these companies violated the False Claims Act by failing to reveal their knowledge about the presence of NDMA in their product. The probes...

Continue Reading

| Read Time: 2 minutes | Dangerous Drugs

Zantac Cancer Lawsuits Consolidated in Southern Florida District Court

July 5, 2020 – Two more Zantac cancer lawsuits were consolidated into the U.S. District Court of Florida, where the Zantac litigation is pending. The two plaintiffs, one from Pennsylvania and the other from Florida, were both women who claimed that regular use of Zantac lead them (or their decedent) to develop cancer. The Pennsylvania-based plaintiff filed a claim on...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Incretin Mimetics Cases in 2020

June 15, 2020 — There are 986 cases pending as of June 15, 2020. Reference:  “Pending MDL Dockets by District.” Judicial Panel on Multidistrict Litigation, www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-June-15-2020.pdf.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Schedule For Zantac Discovery and Case Management

June 18, 2020 — On June 18, 2020,  Judge Rosenberg ordered a schedule for discovery and case management in Pretrial Order #30.  The schedule runs from June 15, 2020, which was the beginning of fact discovery, to August 3, 2022. Reference:  “United States District Court.” 20-MD-2924-Rosenberg – In Re: Zantac (Ranitidine) Products Liability Litigation | Southern District of Florida...

Continue Reading